End-of-day quote
Shanghai S.E.
06:00:00 2024-05-05 pm EDT
|
5-day change
|
1st Jan Change
|
9.28
CNY
|
+1.53%
|
|
+4.15%
|
-13.83%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
19,431
|
21,083
|
23,527
|
18,287
|
9,846
|
10,366
|
10,366
|
-
|
Enterprise Value (EV)
1 |
19,431
|
20,015
|
22,011
|
16,954
|
8,451
|
10,000
|
8,633
|
8,865
|
P/E ratio
|
25.2
x
|
93.6
x
|
58
x
|
48.1
x
|
47.4
x
|
41.4
x
|
28.5
x
|
22.5
x
|
Yield
|
2.11%
|
0.32%
|
0.57%
|
0.67%
|
0.67%
|
0.74%
|
1.04%
|
1.32%
|
Capitalization / Revenue
|
10.2
x
|
18.7
x
|
14.9
x
|
10.3
x
|
6.44
x
|
7.33
x
|
5.61
x
|
4.45
x
|
EV / Revenue
|
10.2
x
|
17.8
x
|
13.9
x
|
9.54
x
|
5.53
x
|
6.26
x
|
4.67
x
|
3.8
x
|
EV / EBITDA
|
19.7
x
|
55.4
x
|
33.8
x
|
30
x
|
18.6
x
|
19.8
x
|
15.8
x
|
12.8
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
70.6
x
|
49.3
x
|
32.7
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
1.42%
|
2.03%
|
3.06%
|
Price to Book
|
3.86
x
|
4.54
x
|
4.72
x
|
3.49
x
|
1.99
x
|
2.25
x
|
1.84
x
|
1.72
x
|
Nbr of stocks (in thousands)
|
1,170,537
|
1,126,240
|
1,126,240
|
1,118,482
|
1,092,777
|
1,117,068
|
1,117,068
|
-
|
Reference price
2 |
16.60
|
18.72
|
20.89
|
16.35
|
9.010
|
9.280
|
9.280
|
9.280
|
Announcement Date
|
4/28/19
|
3/29/20
|
4/22/21
|
4/21/22
|
4/20/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,897
|
1,127
|
1,582
|
1,776
|
1,529
|
1,598
|
1,847
|
2,331
|
EBITDA
1 |
986.4
|
361.1
|
651.9
|
565.5
|
454.3
|
503.9
|
546.9
|
694.6
|
EBIT
1 |
889.2
|
253.6
|
477.8
|
414.7
|
255.1
|
315.2
|
421.8
|
533
|
Operating Margin
|
46.89%
|
22.51%
|
30.2%
|
23.34%
|
16.69%
|
19.72%
|
22.83%
|
22.86%
|
Earnings before Tax (EBT)
1 |
889.3
|
253.5
|
476.2
|
413.3
|
245.6
|
315.8
|
421.9
|
537.9
|
Net income
1 |
754.5
|
221
|
406.2
|
382.3
|
210.7
|
283.6
|
363.4
|
461.1
|
Net margin
|
39.78%
|
19.62%
|
25.68%
|
21.52%
|
13.78%
|
17.75%
|
19.67%
|
19.78%
|
EPS
2 |
0.6600
|
0.2000
|
0.3600
|
0.3400
|
0.1900
|
0.2600
|
0.3262
|
0.4116
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
141.7
|
175
|
271
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
8.86%
|
9.47%
|
11.62%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
28.11%
|
32%
|
39.01%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
49.95%
|
48.15%
|
58.77%
|
Dividend per Share
2 |
0.3500
|
0.0600
|
0.1200
|
0.1100
|
0.0600
|
0.0800
|
0.0965
|
0.1225
|
Announcement Date
|
4/28/19
|
3/29/20
|
4/22/21
|
4/21/22
|
4/20/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 S1
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
437.9
|
-
|
420.3
|
364
|
-
|
534.3
|
379.2
|
347.9
|
380
|
590
|
532
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-39.5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-9.02%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
104.9
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-0.0300
|
0.0900
|
-
|
-
|
0.0200
|
0.1400
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/21/22
|
8/29/22
|
4/20/23
|
4/20/23
|
8/24/23
|
10/30/23
|
4/25/24
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,068
|
1,516
|
1,334
|
1,395
|
1,711
|
1,734
|
1,501
|
1,920
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
142
|
175
|
271
|
-
|
ROE (net income / shareholders' equity)
|
4.49%
|
8.37%
|
7.39%
|
3.96%
|
5.43%
|
6.49%
|
8.04%
|
8.12%
|
ROA (Net income/ Total Assets)
|
3.72%
|
6.85%
|
5.94%
|
-
|
-
|
5.13%
|
6.48%
|
6.48%
|
Assets
1 |
5,950
|
5,932
|
6,441
|
-
|
-
|
7,080
|
7,116
|
8,858
|
Book Value Per Share
2 |
4.130
|
4.420
|
4.680
|
4.530
|
4.790
|
5.050
|
5.400
|
5.750
|
Cash Flow per Share
2 |
0.3600
|
0.6200
|
0.4700
|
0.3100
|
0.3700
|
0.3700
|
0.3400
|
-
|
Capex
1 |
307
|
227
|
372
|
190
|
273
|
155
|
149
|
85
|
Capex / Sales
|
27.23%
|
14.33%
|
20.95%
|
12.42%
|
17.09%
|
8.37%
|
6.41%
|
3.09%
|
Announcement Date
|
3/29/20
|
4/22/21
|
4/21/22
|
4/20/23
|
4/25/24
|
-
|
-
|
-
|
Last Close Price
9.28
CNY Average target price
9.38
CNY Spread / Average Target +1.08% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.83% | 1.37B | | -15.92% | 76.23B | | -11.01% | 6.67B | | +27.50% | 3.7B | | -1.25% | 3.21B | | +4.73% | 1.52B | | -23.86% | 1.24B | | -8.01% | 1.21B | | -8.44% | 1.17B | | +0.67% | 1.05B |
Veterinary Drugs
|